Article Versions Notes

Seo S, Kim KL, Yeo Y, Kim R-I, Jeong H, Kim J-O, Song S-H, An M-J, Kim J-W, Hong HK, et al. A Fully Human Monoclonal Antibody Targeting cKIT Is a Potent Inhibitor of Pathological Choroidal Neovascularization in Mice. Pharmaceutics. 2021; 13(8):1308. https://doi.org/10.3390/pharmaceutics13081308

Seo, Songyi, Koung Li Kim, Yeongju Yeo, Ryul-I Kim, Hayoung Jeong, Jin-Ock Kim, Sun-Hwa Song, Mi-Jin An, Jung-Woong Kim, Hye Kyoung Hong, and et al. 2021. "A Fully Human Monoclonal Antibody Targeting cKIT Is a Potent Inhibitor of Pathological Choroidal Neovascularization in Mice" Pharmaceutics 13, no. 8: 1308. https://doi.org/10.3390/pharmaceutics13081308

Seo, S., Kim, K. L., Yeo, Y., Kim, R.-I., Jeong, H., Kim, J.-O., Song, S.-H., An, M.-J., Kim, J.-W., Hong, H. K., Ham, M. H., Woo, S. J., Sung, J.-H., Park, S. G., & Suh, W. (2021). A Fully Human Monoclonal Antibody Targeting cKIT Is a Potent Inhibitor of Pathological Choroidal Neovascularization in Mice. Pharmaceutics, 13(8), 1308. https://doi.org/10.3390/pharmaceutics13081308